The advent of CFTR modulators has undoubtedly changed the clinical course of CF, leading to significant improvements in the lives of a large proportion of people with CF, whose life expectancy has increased from 5 years in 1960 to over 50 years. The gene discussed is CFTR; the disease is cystic fibrosis.